Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    90.00 (2.45%)
Bid:
3,744.00
Ask:
3,748.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Interim Management Statement

23 Apr 2009 07:00

RNS Number : 0174R
4imprint Group PLC
23 April 2009
 



4imprint Group plc

Interim Management Statement 

The Board of 4imprint Group plc issues its interim management statement for the period 28 December 2008 to 28 March 2009. Seasonally, the first quarter is the least strong of any quarter of the year, and particularly so for the Direct Marketing Divisionwhich is the largest Division in the Group and in quarter one (Q1) represented 63% of total Group sales.

Group sales for the quarter were £35.72m; 10% ahead of the first quarter last year. At constant currency, sales were 12% lower than in Q1 2008.

Sales performances in each of the three divisions of the Group were as follows:-

(a) End User Division

Q1 sales at £9.92m were 15% lower than Q1 2008. The Manchester based Brand Addition business experienced weak markets carrying into 2009 from the end of last year, and sales were 25% down on Q1 2008. Sales in the Kreyer business were 6% below prior year in sterling and 21% behind in local currencyHowever, the effect on profitability of these two businesses was partly mitigated by cost reduction actions implemented in the first quarter. Sales in PPI have been maintained at a similar level to prior year.

(b) Trade Division

Q1 sales in the Trade Division, including inter divisional salesat £3.90m were 19% down on the same period last year, again reflecting the carry through of the weak trading conditions in the final quarter of 2008.  It is particularly noteworthy that the effect of lower sales during the quarter was completely offset by the major cost reduction implemented during 2008. The Division is now able to focus maximum effort on expanding sales in home and export markets.

(c) Direct Marketing Division

Q1 sales for the Direct Marketing Division at £22.4m were 33% ahead of the same period last year. Constant currency sales in North America in Q1 were 3% below Q1 2008. 

(i) North America 

Over recent years, the Direct Marketing Division has grown rapidly as the Board pursued a strategy of aggressive investment in new customer acquisition through the expansion and development of internet and print marketing techniques. 

Notwithstanding the weaker trading climate in North America from October 2008 onwards, the Board has elected to maintain this prospecting investment, which is a crucial tool in the sustained growth of this important business. In the current trading climate, however, the yields from this investment have reduced and the effect has been amplified by lower average order values than last year, as customers seek to reduce their own costs. Consequently, profitability has been affected and particularly in Q1, which as stated earlier is seasonally the weakest. Most importantly, however, customer retention patterns from customers acquired during the year, as well as those acquired in prior years, have been maintained and total orders have been similar to those of Q1 2008. The business is thus well positioned to continue to gain market share and pursue its opportunity for strong future growth when the economy improves

(ii) UK

Sales continued to grow strongly in this business and were 20% ahead of the same period last year.

Outlook

Trading conditions in our markets continue to look uncertain. However, the Board believes that the range of actions to pursue new sales opportunities coupled with actions already taken to align the cost base and maximise cash flow, should underpin the Group's performance during the coming months.  

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDSRSDGGCD
Date   Source Headline
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.